Standard BioTools Inc., headquartered in the United States, is a pioneering company in the life sciences industry, specialising in innovative tools for biological research and diagnostics. Founded in 2019, the company has rapidly established itself as a leader in single-cell analysis and genomic technologies, providing researchers with advanced solutions that enhance precision and efficiency. With a focus on core products such as the Standard BioTools™ platform, the company offers unique capabilities in multiplexed protein analysis and genomic sequencing. These cutting-edge tools empower scientists to unlock complex biological data, driving advancements in personalised medicine and therapeutic development. Standard BioTools Inc. has garnered recognition for its commitment to innovation, positioning itself as a key player in the global market for life science tools and technologies.
How does Standard BioTools Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Standard BioTools Inc.'s score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Standard BioTools Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company at this time. As a result, Standard BioTools Inc. appears to be in the early stages of establishing its climate commitments and emissions reduction strategies. Without specific data or targets, it is challenging to assess their current environmental impact or future commitments in the context of industry standards. The company may benefit from developing a comprehensive sustainability strategy that includes measurable emissions targets and participation in recognised initiatives, such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP), to enhance its climate accountability and performance.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Standard BioTools Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.